Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

Phosphorylated Neurofilament H Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:pNF-H
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


RD191138300R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA, HRP-labelled antibody

Applications

Serum, Cerebrospinal fluid, Tissue extract, Plasma

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

62.5–4000 pg/ml

Limit of Detection

23.5 pg/ml

Intra-assay (Within-Run)

n = 8; CV = 4.5%

Spiking Recovery

CSF sample: 98.8%
Serum sample: 95.8%

Dilution Linearity

CSF sample: 106.1%
Serum sample: 105.5%

Summary

Features

  • It is intended for research use only.
  • The total assay time is less than 4 hours.
  • The kit measures pNF-H in serum, plasma, cerebrospinal fluid (CSF) and tissue samples
  • Assay format is 96 wells.
  • Standard and Quality Controls are human brain extract based. No animal sera are used.
  • Components of the kit are provided ready to use, concentrated or lyophilized.

Research topic

Neural tissue markers, Oncology

Product References (29)

References

  • Cai JY, Lu C, Chen MH, Ba HJ, Chen XD, Lin JH, Sun J. Predictive value ofphosphorylated axonal neurofilament subunit H for clinical outcome in patientswith acute intracerebral hemorrhage. Clin Chim Acta. 2013 Sep 23;424:182-6. doi: 10.1016/j.cca.2013.06.019. Epub 2013 Jun 26. PubMed PMID: 23810564. See more on PubMed
  • Chen X, Chen Y, Wei Q, Ou R, Cao B, Zhao B, Shang HF. Assessment of a multiplebiomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol. 2016 Sep 15;16:173. doi: 10.1186/s12883-016-0689-x. PubMed PMID: 27634542; PubMedCentral PMCID: PMC5024522. See more on PubMed
  • Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML,Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M,Jahn H; FTLDc study group. Specific serum and CSF microRNA profiles distinguishsporadic behavioural variant of frontotemporal dementia compared with Alzheimerpatients and cognitively healthy controls. PLoS One. 2018 May 10;13(5):e0197329. doi: 10.1371/journal.pone.0197329. eCollection 2018. PubMed PMID: 29746584;PubMed Central PMCID: PMC5945001. See more on PubMed
  • Fialová L, Bartos A, Švarcová J, Zimova D, Kotoucova J. Serum andcerebrospinal fluid heavy neurofilaments and antibodies against them in earlymultiple sclerosis. J Neuroimmunol. 2013 Jun 15;259(1-2):81-7. doi:10.1016/j.jneuroim.2013.03.009. Epub 2013 Apr 28. PubMed PMID: 23632043. See more on PubMed
  • Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. Combination ofneurofilament heavy chain and complement C3 as CSF biomarkers for ALS. JNeurochem. 2011 May;117(3):528-37. doi: 10.1111/j.1471-4159.2011.07224.x. Epub2011 Mar 21. PubMed PMID: 21418221; PubMed Central PMCID: PMC3076545. See more on PubMed
  • Gonçalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J.Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin Chim Acta. 2015 Jan 1;438:342-9. doi:10.1016/j.cca.2014.09.011. Epub 2014 Sep 28. PubMed PMID: 25261856. See more on PubMed
  • Gresle MM, Butzkueven H, Shaw G. Neurofilament proteins as body fluidbiomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int.2011;2011:315406. doi: 10.1155/2011/315406. Epub 2011 Jan 23. PubMed PMID:22096635; PubMed Central PMCID: PMC3195785. See more on PubMed
  • Inoue R, Sumitani M, Ogata T, Chikuda H, Matsubara T, Kato S, Shimojo N,Uchida K, Yamada Y. Direct evidence of central nervous system axonal damage inpatients with postoperative delirium: A preliminary study of pNF-H as a promisingserum biomarker. Neurosci Lett. 2017 Jul 13;653:39-44. doi:10.1016/j.neulet.2017.05.023. Epub 2017 May 11. PubMed PMID: 28504118. See more on PubMed
  • Kuwajima K, Sumitani M, Kurano M, Kano K, Nishikawa M, Uranbileg B, TsuchidaR, Ogata T, Aoki J, Yatomi Y, Yamada Y. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study. PLoS One. 2018 Nov8;13(11):e0207310. doi: 10.1371/journal.pone.0207310. eCollection 2018. PubMedPMID: 30408112; PubMed Central PMCID: PMC6224112. See more on PubMed
  • Lehmer C, Oeckl P, Weishaupt JH, Volk AE, Diehl-Schmid J, Schroeter ML, Lauer M, Kornhuber J, Levin J, Fassbender K, Landwehrmeyer B; German Consortium forFrontotemporal Lobar Degeneration, Schludi MH, Arzberger T, Kremmer E, Flatley A,Feederle R, Steinacker P, Weydt P, Ludolph AC, Edbauer D, Otto M. Poly-GP incerebrospinal fluid links C9orf72-associated dipeptide repeat expression to theasymptomatic phase of ALS/FTD. EMBO Mol Med. 2017 Jul;9(7):859-868. doi:10.15252/emmm.201607486. PubMed PMID: 28408402; PubMed Central PMCID: PMC5494528. See more on PubMed
  • Li S, Ren Y, Zhu W, Yang F, Zhang X, Huang X. Phosphorylated neurofilamentheavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. JNeurol Sci. 2016 Aug 15;367:269-74. doi: 10.1016/j.jns.2016.05.062. Epub 2016 Jun1. PubMed PMID: 27423602. See more on PubMed
  • McGuire JL, Gill AJ, Douglas SD, Kolson DL; CNS HIV Anti-Retroviral TherapyEffects Research (CHARTER) group. Central and peripheral markers ofneurodegeneration and monocyte activation in HIV-associated neurocognitivedisorders. J Neurovirol. 2015 Aug;21(4):439-48. doi: 10.1007/s13365-015-0333-3.Epub 2015 Mar 17. PubMed PMID: 25776526; PubMed Central PMCID: PMC4511078. See more on PubMed
  • Natori A, Ogata T, Sumitani M, Kogure T, Yamauchi T, Yamauchi H. Potentialrole of pNF-H, a biomarker of axonal damage in the central nervous system, as apredictive marker of chemotherapy-induced cognitive impairment. Clin Cancer Res. 2015 Mar 15;21(6):1348-52. doi: 10.1158/1078-0432.CCR-14-2775. Epub 2015 Jan 14. PubMed PMID: 25589615. See more on PubMed
  • Pawliszak W, Szwed K, Słomka A, Piekuś-Słomka N, Szwed M, Kowalewski M,Żekanowska E, Borkowska A. Three-vessel coronary artery disease may predictchanges in biochemical brain injury markers after off-pump coronary artery bypassgrafting(). J Zhejiang Univ Sci B. 2018 Sept.;19(9):735-738. doi:10.1631/jzus.B1700553. PubMed PMID: 30178640; PubMed Central PMCID: PMC6137419. See more on PubMed
  • Pironkova RP, Giamelli J, Seiden H, Parnell VA, Gruber D, Sison CP, Kowal C,Ojamaa K. Brain injury with systemic inflammation in newborns with congenitalheart disease undergoing heart surgery. Exp Ther Med. 2017 Jul;14(1):228-238.doi: 10.3892/etm.2017.4493. Epub 2017 May 22. PubMed PMID: 28672919; PubMedCentral PMCID: PMC5488503. See more on PubMed
  • Pranzatelli MR, Tate ED, McGee NR, Verhulst SJ. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatricneuroinflammatory disorders. J Neuroimmunol. 2014 Jan 15;266(1-2):75-81. doi:10.1016/j.jneuroim.2013.11.004. Epub 2013 Nov 16. PubMed PMID: 24342231. See more on PubMed
  • Qiao X, Zhang S, Zhao W, Ye H, Yang Y, Zhang Z, Miao Q, Hu R, Li Y, Lu B.Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, isAssociated With Peripheral Neuropathy in Patients With Type 2 Diabetes. Medicine (Baltimore). 2015 Nov;94(44):e1908. doi: 10.1097/MD.0000000000001908. PubMedPMID: 26554790; PubMed Central PMCID: PMC4915891. See more on PubMed
  • Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, AndersenPM, von Arnim CA, Böhm S, Kassubek J, Kubisch C, Lulé D, Müller HP, Muche R,Pinkhardt E, Oeckl P, Rosenbohm A, Anderl-Straub S, Volk AE, Weydt P, Ludolph AC,Otto M. Neurofilaments in the diagnosis of motoneuron diseases: a prospectivestudy on 455 patients. J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):12-20. doi: 10.1136/jnnp-2015-311387. Epub 2015 Aug 21. PubMed PMID: 26296871. See more on PubMed
  • Sumitani M, Ogata T, Natori A, Hozumi J, Shimojo N, Kida K, Yamauchi H,Yamauchi T. Poor efficacy of the phosphorylated high-molecular-weightneurofilament heavy subunit serum level, a biomarker of axonal damage, as amarker of chemotherapy-induced peripheral neuropathy. Biomed Rep. 2016Jun;4(6):758-760. Epub 2016 Apr 8. PubMed PMID: 27284419; PubMed Central PMCID:PMC4887842. See more on PubMed
  • Takahashi H, Aoki Y, Nakajima A, Sonobe M, Terajima F, Saito M, Taniguchi S,Yamada M, Watanabe F, Furuya T, Koda M, Yamazaki M, Takahashi K, Nakagawa K.Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinalfluid of patients with acutely worsening symptoms of compression myelopathy. JClin Neurosci. 2014 Dec;21(12):2175-8. doi: 10.1016/j.jocn.2014.04.021. Epub 2014Jul 22. PubMed PMID: 25065845. See more on PubMed
  • Vajtr D, Benada O, Linzer P, Sámal F, Springer D, Strejc P, Beran M, Průša R, Zima T. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek. 2012Jan;57(1):7-12. PubMed PMID: 22724589. See more on PubMed
  • Yang Z, Bramlett HM, Moghieb A, Yu D, Wang P, Lin F, Bauer C, Selig TM,Jaalouk E, Weissman AS, Rathore DS, Romo P, Zhang Z, Hayes RL, Wang MY, Dietrich WD, Wang KKW. Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers. Mol Neurobiol. 2018 Mar;55(3):2174-2184. doi:10.1007/s12035-017-0424-7. Epub 2017 Mar 13. PubMed PMID: 28290147. See more on PubMed
  • Yokobori S, Wang KKK, Yang Z, Zhu T, Tyndall JA, Mondello S, Shibata Y,Tominaga N, Kanaya T, Takiguchi T, Igarashi Y, Hagiwara J, Nakae R, Onda H,Masuno T, Fuse A, Yokota H. Quantitative pupillometry and neuron-specific enolaseindependently predict return of spontaneous circulation following cardiogenicout-of-hospital cardiac arrest: a prospective pilot study. Sci Rep. 2018 Oct29;8(1):15964. doi: 10.1038/s41598-018-34367-x. PubMed PMID: 30374189; PubMedCentral PMCID: PMC6206016. See more on PubMed
  • Zurek J, Bartlová L, Fedora M. Hyperphosphorylated neurofilament NF-H as apredictor of mortality after brain injury in children. Brain Inj.2011;25(2):221-6. doi: 10.3109/02699052.2010.541895. PubMed PMID: 21219092. See more on PubMed
  • Žurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic braininjury. Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. doi:10.1007/s00701-011-1175-2. PubMed PMID: 21976236. See more on PubMed
  • Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C, Steiner J, Nath A, Haughey N, McArthur J. Paroxetine and fluconazole therapy for HIV-associatedneurocognitive impairment: results from a double-blind, placebo-controlled trial.J Neurovirol. 2018 Feb;24(1):16-27. doi: 10.1007/s13365-017-0587-z. Epub 2017 Oct23. PubMed PMID: 29063516; PubMed Central PMCID: PMC5792316. See more on PubMed
  • Singh A, Kumar V, Ali S, Mahdi AA, Srivastava RN. Phosphorylated neurofilamentheavy: A potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illn Inj Sci. 2017 Oct-Dec;7(4):212-217. doi:10.4103/IJCIIS.IJCIIS_73_16. PubMed PMID: 29291173; PubMed Central PMCID:PMC5737062. See more on PubMed
  • Sandsmark DK, Bogoslovsky T, Qu BX, Haber M, Cota MR, Davis C, Butman JA,Latour LL, Diaz-Arrastia R. Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury. Front Neurol. 2019 Mar26;10:246. doi: 10.3389/fneur.2019.00246. eCollection 2019. PubMed PMID:30972003; PubMed Central PMCID: PMC6445052. See more on PubMed
  • Wurster CD, Günther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z,Witzel S, Kocak T, Winter B, Koch JC, Lingor P, Petri S, Ludolph AC, Hermann A,Otto M. Neurochemical markers in CSF of adolescent and adult SMA patientsundergoing nusinersen treatment. Ther Adv Neurol Disord. 2019 May10;12:1756286419846058. doi: 10.1177/1756286419846058. eCollection 2019. PubMedPMID: 31205491; PubMed Central PMCID: PMC6535708. See more on PubMed
Summary References (7)

References to Phosphorylated Neurofilament H

  • Anderson KJ, Scheff SW, Miller KM, Roberts KN, Gilmer LK, Yang C, Shaw G. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma. 2008 Sep;25 (9):1079-85
  • Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Iqbal K, Grundke-Iqbal I, Wang JZ. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett. 2002 Mar 8;320 (3):156-60
  • Lewis SB, Wolper RA, Miralia L, Yang C, Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab. 2008 Jun;28 (6):1261-71
  • Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 2005 Jun 15;233 (1-2):183-98
  • Petzold A, Rejdak K, Plant GT. Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry. 2004 Aug;75 (8):1178-80
  • Petzold A, Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods. 2007 Jan 30;319 (1-2):34-40
  • Shaw G, Yang C, Ellis R, Anderson K, Parker Mickle J, Scheff S, Pike B, Anderson DK, Howland DR. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun. 2005 Nov 4;336 (4):1268-77
Related Products Docs